BBOT logo

BBOTBridgeBio Oncology Therapeutics Inc.

$8.27
$0.28
(3.27%)
Today
Closed $8.27
$0.00
(0.00%)
After Hours
Updated: 04:10 PM EDT
Reported EarningsMay 12
Mkt Cap$684.92M
Vol135,439.00

About

Bridgebio Oncology Therapeutics, Inc. engages in developing bioavailable small molecule inhibitors. It focuses on advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Ka malignancies. The company was founded on August 1, 2016 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
92

Frequently Asked Questions

What is Market Cap of BridgeBio Oncology Therapeutics Inc.?
What is the 52-week high for BridgeBio Oncology Therapeutics Inc.?
What is the 52-week low for BridgeBio Oncology Therapeutics Inc.?
What is BridgeBio Oncology Therapeutics Inc. stock price today?
What was BridgeBio Oncology Therapeutics Inc. stock price yesterday?
What is the PE ratio of BridgeBio Oncology Therapeutics Inc.?
What is the Price-to-Book ratio of BridgeBio Oncology Therapeutics Inc.?
What is the 50-day moving average of BridgeBio Oncology Therapeutics Inc.?
How many employees does BridgeBio Oncology Therapeutics Inc. have?